All   Articles   Authors   Suppliers   N&N
Closed System Transfer Devices for Drug Preparation
April 2011 : State of Pharmacy Compounding - Vol. 8 No. 4 - Page #14
Download   Print   Digital Edition    Share

Recognizing the safety risks in hazardous drug transfer, 44% of facilities have incorporated closed system transfer devices (CSTDs) into the compounding process. Those who have not adopted CSTDs cited budget constraints as the most common reason for not doing so. 

For more information on closed system transfer devices, visit www.pppmag.com/info and click on Closed System Transfer Devices.

To view the PDF, click the download link above.

What is the size of your Facility?
  • 1 - 100
  • 101 - 200
  • 201 - 300
  • 301 - 400
  • 400+

Subscribe to PP&P Magazine

This article is archival PPPMAG content.

We require our users to register to view content older than 0 months. Please take a moment to register with us. Registration is free, and a quick single step process.

Our mission is to provide health system pharmacists with information to streamline pharmacy operations and promote patient safety.

As a requester to PP&P you will receive all monthly issues, as well as our annual Resource Guide of product and service providers and all of our timely supplements on pharmacy's hot-button issues.

Thank you for reading PP&P, and we look forward to providing you with information to enhance the field of pharmacy.

Already a member? Please provide your email and password below:

Email:
Password:
Remember me

Page generated in 0.0066 seconds.